N-[4-[[4-chloro-8-(2-morpholin-4-yl-4-pyridinyl)-3,7-diazabicyclo[4.2.0]octa-1,3,5,7-tetraen-2-yl]oxy]oxan-2-yl]-3-[1-(2-methylpropyl)pyrazol-4-yl]-4-(oxan-4-yloxy)-1H-pyrazolo[4,3-c]pyridine-6-carbonitrilium

C39H42ClN10O5+ — CID 123611089

IUPACN-[4-[[4-chloro-8-(2-morpholin-4-yl-4-pyridinyl)-3,7-diazabicyclo[4.2.0]octa-1,3,5,7-tetraen-2-yl]oxy]oxan-2-yl]-3-[1-(2-methylpropyl)pyrazol-4-yl]-4-(oxan-4-yloxy)-1H-pyrazolo[4,3-c]pyridine-6-carbonitrilium
SMILESCC(C)Cn1cc(-c2n[nH]c3cc(C#[N+]C4CC(Oc5nc(Cl)cc6c5C(c5ccnc(N7CCOCC7)c5)=N6)CCO4)nc(OC4CCOCC4)c23)cn1
InChIInChI=1S/C39H41ClN10O5/c1-23(2)21-50-22-25(19-43-50)37-35-30(47-48-37)16-26(44-38(35)54-27-4-10-51-11-5-27)20-42-33-17-28(6-12-53-33)55-39-34-29(18-31(40)46-39)45-36(34)24-3-7-41-32(15-24)49-8-13-52-14-9-49/h3,7,15-16,18-19,22-23,27-28,33H,4-6,8-14,17,21H2,1-2H3/p+1
InChIKeyXQARIJBKJAZHJV-UHFFFAOYSA-O
MW766.28 g/mol
LogP6.06
Rot. Bonds9

About N-[4-[[4-chloro-8-(2-morpholin-4-yl-4-pyridinyl)-3,7-diazabicyclo[4.2.0]octa-1,3,5,7-tetraen-2-yl]oxy]oxan-2-yl]-3-[1-(2-methylpropyl)pyrazol-4-yl]-4-(oxan-4-yloxy)-1H-pyrazolo[4,3-c]pyridine-6-carbonitrilium

N-[4-[[4-chloro-8-(2-morpholin-4-yl-4-pyridinyl)-3,7-diazabicyclo[4.2.0]octa-1,3,5,7-tetraen-2-yl]oxy]oxan-2-yl]-3-[1-(2-methylpropyl)pyrazol-4-yl]-4-(oxan-4-yloxy)-1H-pyrazolo[4,3-c]pyridine-6-carbonitrilium (PubChem CID 123611089) has the molecular formula C39H42ClN10O5+ and a molecular weight of 766.28 g/mol. Its IUPAC name is N-[4-[[4-chloro-8-(2-morpholin-4-yl-4-pyridinyl)-3,7-diazabicyclo[4.2.0]octa-1,3,5,7-tetraen-2-yl]oxy]oxan-2-yl]-3-[1-(2-methylpropyl)pyrazol-4-yl]-4-(oxan-4-yloxy)-1H-pyrazolo[4,3-c]pyridine-6-carbonitrilium.

Molecular Properties

Compound NameN-[4-[[4-chloro-8-(2-morpholin-4-yl-4-pyridinyl)-3,7-diazabicyclo[4.2.0]octa-1,3,5,7-tetraen-2-yl]oxy]oxan-2-yl]-3-[1-(2-methylpropyl)pyrazol-4-yl]-4-(oxan-4-yloxy)-1H-pyrazolo[4,3-c]pyridine-6-carbonitrilium
PubChem CID123611089
Molecular FormulaC39H42ClN10O5+
Molecular Weight766.28 g/mol
Exact Mass765.30
IUPAC NameN-[4-[[4-chloro-8-(2-morpholin-4-yl-4-pyridinyl)-3,7-diazabicyclo[4.2.0]octa-1,3,5,7-tetraen-2-yl]oxy]oxan-2-yl]-3-[1-(2-methylpropyl)pyrazol-4-yl]-4-(oxan-4-yloxy)-1H-pyrazolo[4,3-c]pyridine-6-carbonitrilium
SMILESCC(C)Cn1cc(-c2n[nH]c3cc(C#[N+]C4CC(Oc5nc(Cl)cc6c5C(c5ccnc(N7CCOCC7)c5)=N6)CCO4)nc(OC4CCOCC4)c23)cn1
InChIInChI=1S/C39H41ClN10O5/c1-23(2)21-50-22-25(19-43-50)37-35-30(47-48-37)16-26(44-38(35)54-27-4-10-51-11-5-27)20-42-33-17-28(6-12-53-33)55-39-34-29(18-31(40)46-39)45-36(34)24-3-7-41-32(15-24)49-8-13-52-14-9-49/h3,7,15-16,18-19,22-23,27-28,33H,4-6,8-14,17,21H2,1-2H3/p+1
InChIKeyXQARIJBKJAZHJV-UHFFFAOYSA-O
XLogP6.06
TPSA151.28 Ų
H-Bond Donors1
H-Bond Acceptors13
Rotatable Bonds9
Heavy Atoms55
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500766.28
LogP ≤ 56.06
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}

Analyze N-[4-[[4-chloro-8-(2-morpholin-4-yl-4-pyridinyl)-3,7-diazabicyclo[4.2.0]octa-1,3,5,7-tetraen-2-yl]oxy]oxan-2-yl]-3-[1-(2-methylpropyl)pyrazol-4-yl]-4-(oxan-4-yloxy)-1H-pyrazolo[4,3-c]pyridine-6-carbonitrilium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[4-[[4-chloro-8-(2-morpholin-4-yl-4-pyridinyl)-3,7-diazabicyclo[4.2.0]octa-1,3,5,7-tetraen-2-yl]oxy]oxan-2-yl]-3-[1-(2-methylpropyl)pyrazol-4-yl]-4-(oxan-4-yloxy)-1H-pyrazolo[4,3-c]pyridine-6-carbonitrilium?
The IUPAC name of N-[4-[[4-chloro-8-(2-morpholin-4-yl-4-pyridinyl)-3,7-diazabicyclo[4.2.0]octa-1,3,5,7-tetraen-2-yl]oxy]oxan-2-yl]-3-[1-(2-methylpropyl)pyrazol-4-yl]-4-(oxan-4-yloxy)-1H-pyrazolo[4,3-c]pyridine-6-carbonitrilium (CID 123611089) is N-[4-[[4-chloro-8-(2-morpholin-4-yl-4-pyridinyl)-3,7-diazabicyclo[4.2.0]octa-1,3,5,7-tetraen-2-yl]oxy]oxan-2-yl]-3-[1-(2-methylpropyl)pyrazol-4-yl]-4-(oxan-4-yloxy)-1H-pyrazolo[4,3-c]pyridine-6-carbonitrilium.
What is the SMILES notation for N-[4-[[4-chloro-8-(2-morpholin-4-yl-4-pyridinyl)-3,7-diazabicyclo[4.2.0]octa-1,3,5,7-tetraen-2-yl]oxy]oxan-2-yl]-3-[1-(2-methylpropyl)pyrazol-4-yl]-4-(oxan-4-yloxy)-1H-pyrazolo[4,3-c]pyridine-6-carbonitrilium?
The canonical SMILES for N-[4-[[4-chloro-8-(2-morpholin-4-yl-4-pyridinyl)-3,7-diazabicyclo[4.2.0]octa-1,3,5,7-tetraen-2-yl]oxy]oxan-2-yl]-3-[1-(2-methylpropyl)pyrazol-4-yl]-4-(oxan-4-yloxy)-1H-pyrazolo[4,3-c]pyridine-6-carbonitrilium is CC(C)Cn1cc(-c2n[nH]c3cc(C#[N+]C4CC(Oc5nc(Cl)cc6c5C(c5ccnc(N7CCOCC7)c5)=N6)CCO4)nc(OC4CCOCC4)c23)cn1.
What is the InChIKey of N-[4-[[4-chloro-8-(2-morpholin-4-yl-4-pyridinyl)-3,7-diazabicyclo[4.2.0]octa-1,3,5,7-tetraen-2-yl]oxy]oxan-2-yl]-3-[1-(2-methylpropyl)pyrazol-4-yl]-4-(oxan-4-yloxy)-1H-pyrazolo[4,3-c]pyridine-6-carbonitrilium?
The InChIKey is XQARIJBKJAZHJV-UHFFFAOYSA-O. The full InChI is InChI=1S/C39H41ClN10O5/c1-23(2)21-50-22-25(19-43-50)37-35-30(47-48-37)16-26(44-38(35)54-27-4-10-51-11-5-27)20-42-33-17-28(6-12-53-33)55-39-34-29(18-31(40)46-39)45-36(34)24-3-7-41-32(15-24)49-8-13-52-14-9-49/h3,7,15-16,18-19,22-23,27-28,33H,4-6,8-14,17,21H2,1-2H3/p+1.
What are the key properties of N-[4-[[4-chloro-8-(2-morpholin-4-yl-4-pyridinyl)-3,7-diazabicyclo[4.2.0]octa-1,3,5,7-tetraen-2-yl]oxy]oxan-2-yl]-3-[1-(2-methylpropyl)pyrazol-4-yl]-4-(oxan-4-yloxy)-1H-pyrazolo[4,3-c]pyridine-6-carbonitrilium?
N-[4-[[4-chloro-8-(2-morpholin-4-yl-4-pyridinyl)-3,7-diazabicyclo[4.2.0]octa-1,3,5,7-tetraen-2-yl]oxy]oxan-2-yl]-3-[1-(2-methylpropyl)pyrazol-4-yl]-4-(oxan-4-yloxy)-1H-pyrazolo[4,3-c]pyridine-6-carbonitrilium has a molecular weight of 766.28 g/mol, XLogP of 6.06, 9 rotatable bonds, 1 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[[4-chloro-8-(2-morpholin-4-yl-4-pyridinyl)-3,7-diazabicyclo[4.2.0]octa-1,3,5,7-tetraen-2-yl]oxy]oxan-2-yl]-3-[1-(2-methylpropyl)pyrazol-4-yl]-4-(oxan-4-yloxy)-1H-pyrazolo[4,3-c]pyridine-6-carbonitrilium is sourced from PubChem (CID 123611089), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).